Enforcement Report News Today

Newsroom is open 24 hours, please reach us by email at info@canyon-news.com or by phone Monday through Friday 9-5. You can place DBA (Fictitious Business Name Statement) orders online by clicking on the link Legal Filings

ICRA assigns A1+ rating to Vedanta's commercial paper, JioFinance launches super-app, Orient Electric appoints new MD, Sun Pharma recalls products.

Aurobindo Pharma | The company had reported 80 percent rise in consolidated net profit to Rs 909 crore in the Jan-March quarter of FY24 from Rs 508 crore in the same period a year ago.

Drug maker Aurobindo Pharma on Saturday announced that the US Food and Drug Administration (FDA) has classified Eugia Pharma Specialities' (a wholly owned subsidiary of the company) formulation manufacturing facility -- Unit III, as 'Official ...

New Delhi, May 25 (IANS) Drug maker Aurobindo Pharma on Saturday announced that the US Food and Drug Administration (FDA) has classified Eugia Pharma

Stock Market Today | Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 21 May 2024. Domestic equity benchmarks BSE Sensex and NSE Nifty opened on a flat note on Tuesday. Both the indices declined nearly 0.1% each. Within the Nifty pack, ONGC was top gainer.

A recall has been issued for the popular tea brand due to pesticide contamination.

Pharma Stocks: Dr Reddys Laboratories, Sun Pharma and Aurobindo Pharma are recalling products in the US market due to manufacturing issues, as per the latest Enforcement Report of the US Food and Drug Administration (USFDA).

Poor Manufacturing: Dr Reddy's, Sun Pharma, Aurobindo Recall Products In US.

Read more about Dr Reddy's, Sun Pharma, Aurobindo recall products in US on Devdiscourse